Analysts expect Ocular Therapeutix, Inc to report revenue of 13.64 M for Q3 26, against a range of 13.01 M to 14.26 M. The most recent reported quarter, Q2 26, came in at 13.47 M, a 1.0% miss against the 13.61 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 15.43 M | 17.08 M | 10.70 M | 13.46 M | 14.54 M | 13.25 M | 10.79 M | 13.47 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 18.67 M | 18.12 M | 18.45 M | 13.85 M | 15.22 M | 18.80 M | 14.28 M | 14.34 M | 14.26 M | 14.64 M | 14.63 M | 17.10 M | 20.56 M | 21.25 M | 54.47 M | 72.72 M | ||||||||||
| Low Estimate | 17.30 M | 15.27 M | 17.27 M | 11.64 M | 13.31 M | 15.60 M | 12.66 M | 12.88 M | 13.01 M | 12.18 M | 12.06 M | 15.06 M | 18.86 M | 19.45 M | 48.49 M | 67.57 M | ||||||||||
| Consensus Estimate | 17.98 M | 16.70 M | 17.86 M | 12.75 M | 14.27 M | 17.20 M | 13.47 M | 13.61 M | 13.64 M | 13.41 M | 13.34 M | 16.08 M | 19.71 M | 20.35 M | 51.48 M | 70.14 M |
Analysts expect Ocular Therapeutix, Inc to report earnings per share of -0.34 for Q3 26, against a range of -0.35 to -0.33. The most recent reported quarter, Q2 26, came in at -0.35, a 14.6% beat against the -0.41 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.22 | -0.29 | -0.38 | -0.39 | -0.38 | -0.29 | -0.40 | -0.35 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.22 | -0.22 | -0.27 | -0.36 | -0.32 | -0.29 | -0.27 | -0.39 | -0.33 | -0.34 | -0.39 | -0.35 | -0.37 | -0.40 | -0.25 | -0.24 | ||||||||||
| Low Estimate | -0.24 | -0.24 | -0.33 | -0.38 | -0.38 | -0.33 | -0.33 | -0.43 | -0.35 | -0.38 | -0.41 | -0.39 | -0.41 | -0.44 | -0.27 | -0.28 | ||||||||||
| Consensus Estimate | -0.23 | -0.23 | -0.30 | -0.37 | -0.35 | -0.31 | -0.30 | -0.41 | -0.34 | -0.36 | -0.40 | -0.37 | -0.39 | -0.42 | -0.26 | -0.26 |
Pull Wall Street consensus for Ocular Therapeutix, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OCUL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OCUL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OCUL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();